このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
China Biotech Services Holdings マネジメント
マネジメント 基準チェック /24
現在、CEO に関する十分な情報がありません。
主要情報
最高経営責任者
n/a
報酬総額
| CEO給与比率 | n/a |
| CEO在任期間 | no data |
| CEOの所有権 | n/a |
| 経営陣の平均在職期間 | 3.8yrs |
| 取締役会の平均在任期間 | 6.5yrs |
経営陣の近況
Recent updates
Some Shareholders Feeling Restless Over China Biotech Services Holdings Limited's (HKG:8037) P/S Ratio
Jun 26
China Biotech Services Holdings Limited's (HKG:8037) Popularity With Investors Under Threat As Stock Sinks 31%
Mar 07Earnings Not Telling The Story For China Biotech Services Holdings Limited (HKG:8037) After Shares Rise 46%
Jan 18We Think China Biotech Services Holdings (HKG:8037) Might Have The DNA Of A Multi-Bagger
Jan 06Does China Biotech Services Holdings (HKG:8037) Have A Healthy Balance Sheet?
Dec 09These 4 Measures Indicate That China Biotech Services Holdings (HKG:8037) Is Using Debt Safely
Aug 24A Look At The Fair Value Of China Biotech Services Holdings Limited (HKG:8037)
Nov 05Is China Biotech Services Holdings (HKG:8037) A Risky Investment?
Oct 13What China Biotech Services Holdings Limited's (HKG:8037) 35% Share Price Gain Is Not Telling You
Jun 28China Biotech Services Holdings (HKG:8037) Could Become A Multi-Bagger
Mar 16China Biotech Services Holdings (HKG:8037) Knows How To Allocate Capital Effectively
Dec 01Under The Bonnet, China Biotech Services Holdings' (HKG:8037) Returns Look Impressive
Jul 26China Biotech Services Holdings' (HKG:8037) Robust Earnings Are Supported By Other Strong Factors
Apr 05Investors Shouldn't Overlook China Biotech Services Holdings' (HKG:8037) Impressive Returns On Capital
Mar 23Did You Miss China Biotech Services Holdings' (HKG:8037) Whopping 825% Share Price Gain?
Feb 23Chun-Shun Ko Just Bought 27% More Shares In China Biotech Services Holdings Limited (HKG:8037)
Jan 28
What Is The Ownership Structure Like For China Biotech Services Holdings Limited (HKG:8037)?
Jan 11The Trend Of High Returns At China Biotech Services Holdings (HKG:8037) Has Us Very Interested
Dec 08CEO（最高経営責任者
China Biotech Services Holdings CEOがいない、あるいは彼らに関するデータがない。
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Executive Chairman & Compliance Officer | 6.8yrs | HK$5.01m | 55.08% HK$ 212.2m | |
| CTO & Executive Director | 4.5yrs | HK$580.00k | データなし | |
| Executive Director | no data | HK$1.06m | 0% HK$ 0 | |
| Chief Scientific Officer | no data | データなし | データなし | |
| Consultant | 3.1yrs | HK$1.70m | データなし | |
| Company Secretary | 6.7yrs | データなし | データなし |
3.8yrs
平均在職期間
57yo
平均年齢
経験豊富な経営陣: 8037の経営陣は 経験豊富 であると考えられます ( 3.8年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Executive Chairman & Compliance Officer | 6.8yrs | HK$5.01m | 55.08% HK$ 212.2m | |
| CTO & Executive Director | 6.8yrs | HK$580.00k | データなし | |
| Executive Director | 5.8yrs | HK$1.06m | 0% HK$ 0 | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Independent Non-Executive Director | 6.8yrs | HK$240.00k | データなし | |
| Independent Non-Executive Director | 6.3yrs | HK$240.00k | データなし | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Chairman of Scientific Advisory Board | no data | データなし | データなし | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Independent Non Executive Director | no data | データなし | データなし |
6.5yrs
平均在職期間
55.5yo
平均年齢
経験豊富なボード: 8037の 取締役会 は 経験豊富 であると考えられます ( 6.5年の平均在任期間)。